OR WAIT null SECS
Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.
August 04, 2014
The pharma industry makes slow, but steady moves toward commercial-scale continuous processes for small-molecule API manufacturing.
August 02, 2014
Customers are looking to reduce risk, increase performance, and optimize productivity.
Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.
July 02, 2014
The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing.
The Modular Automated Sampling Technology platform allows sampling of bioreactors.
June 18, 2014
The Modular Automated Sampling Technology platform takes online samples from bioreactors and transfers them directly to analytical devices.